| Cat.No. : |
Efna5-880M |
| Product Overview : |
Recombinant Mouse Efna5 (Accession # NP_997537), fused with , was produced in Mouse myeloma cell line, NS0-derived. |
| Source : |
Mammalian cells |
| Species : |
Mouse |
| Tag : |
Fc |
| Predicted N Terminal : |
No results obtained: Gln21 predicted, sequencing might be blocked |
| Form : |
Lyophilized from a 0.2 µm filtered solution in PBS. |
| Bio-activity : |
Measured by its ability to inhibit proliferation of PC-3 human prostate cancer cells.The ED50 for this effect is typically 2.5-10 ng/mL. |
| Molecular Mass : |
Recombinant Mouse Efna5, Fc Chimera has a calculated MW of 48.4 kDa (monomer). In SDS-PAGE migrates as 57-60 kDa, reducing conditions. |
| Purity : |
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| Storage : |
Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC). |
| Reconstitution : |
Reconstitute at 100 µg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin. |
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.